NCT07530315 · RECRUITING

The Exercogs® Study

This trial tests Exercogs, a game-like augmented reality program that mixes brain, balance and social activities. 150 adults 55 and older with at least one dementia risk factor train three times a week for 24 weeks. Researchers track thinking, physical performance and social participation. It is an early-stage study of feasibility, safety and effect, not proven or approved.

You may qualify if

  • Age 55 years or older
  • Presence of ≥1 modifiable risk factor according to the Lancet Commission on Dementia Prevention, Intervention, and Care (2024): low education, untreated hearing or visual loss, hypertension, obesity, smoking, depression, physical inactivity, type 2 diabetes, social isolation, excessive alcohol consumption, history of head trauma, air pollution exposure, high LDL/dyslipidemia; additional social and structural determinants, including poverty, income inequality, wealth shocks, and HIV, that may also contribute to risk (Mostert et al., 2025);
  • Ability and willingness to participate in 60-minute sessions, three times per week, during the 24-week intervention period;
  • Ability to provide written informed consent, or, in cases of reduced decisional capacity, provision of consent by a legally authorized representative.

You're excluded if

  • Clinical diagnosis of Alzheimer's disease or dementia;
  • Severe neurological disorder or unstable medical condition that may interfere with participation;
  • Sensory or language deficits that would prevent understanding of instructions or safe participation;
  • Current participation in another interventional study that may confound outcomes (e.g., cognitive training, physical exercise, or multidomain rehabilitation);
  • Previous experience with Exercogs®.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-04-15

View full record on ClinicalTrials.gov

All APOE4 clinical trials